Schrodinger, Inc. (SDGR) 8-K Current Report: March 12, 2026
Filed: March 12, 2026
Health Care
Pharmaceutical PreparationsSchrodinger, Inc. (SDGR) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
Schrodinger, Inc. 8-K Mar 12, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Therese Abrams designated principal accounting officer effective March 8, 2026; previously VP, Corporate Controller since July 2025
- • Abrams is a CPA with 13+ years at Schrödinger across finance and revenue roles — internal promotion, no external search
- • Outgoing Chief Accounting Officer Jenny Herman departed March 6, 2026; staying through April 10 for transition
- • No compensation changes tied to Abrams' new designation — role elevation without incremental cost
- • Clean transition: no disclosed disagreements, related-party issues, or succession conflicts
Other Schrodinger, Inc. 8-K Filings
Get deeper insights on Schrodinger, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.